ICON Public Limited Company
General ticker "ICLR" information:
- Sector: Health Care
- Industry: Medical - Diagnostics & Research
- Capitalization: $11.7B (TTM average)
ICON Public Limited Company follows the US Stock Market performance with the rate: 23.6%.
Estimated limits based on current volatility of 2.4%: low 166.35$, high 174.48$
Factors to consider:
- Earnings expected soon, date: 2026-10-27 amc
- Total employees count: 40100 (-4.3%) as of 2025
- Earnings for 6 months up through Q2 are below our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [149.86$, 220.34$]
- 2026-12-31 to 2027-12-31 estimated range: [159.02$, 231.85$]
Financial Metrics affecting the ICLR estimates:
- Negative: with PPE of 14.8 at the end of fiscal year the price was high
- Positive: 6.77 < Operating cash flow per share per price, % of 7.25
- Positive: 11.29 < Operating profit margin, % of 12.27
- Positive: 0.90 < Return on assets ratio (scaled to [-100,100]) of 1.39
- Positive: Inventory ratio change, % of 0.50 <= 1.34
- Positive: -16.84 < Industry operating profit margin (median), % of -16.21
- Positive: Interest expense per share per price, % of 1.32 <= 1.42
- Positive: Industry inventory ratio change (median), % of 0.16 <= 0.47
Short-term ICLR quotes
Long-term ICLR plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $8,120.18MM | $8,281.68MM | $8,251.34MM |
| Operating Expenses | $7,164.02MM | $7,183.86MM | $7,238.88MM |
| Operating Income | $956.15MM | $1,097.81MM | $1,012.46MM |
| Non-Operating Income | $-332.07MM | $-228.63MM | $-759.99MM |
| Interest Expense | $336.70MM | $237.24MM | $188.11MM |
| Income(Loss) | $624.08MM | $869.18MM | $252.47MM |
| Taxes | $11.75MM | $77.71MM | $23.13MM |
| Net Income(Loss)* | $612.34MM | $791.47MM | $229.34MM |
| Stockholders Equity | $9,240.74MM | $9,523.00MM | $9,193.38MM |
| Assets | $16,989.86MM | $16,877.68MM | $16,269.78MM |
| Operating Cash Flow | $1,161.03MM | $1,286.65MM | $1,036.20MM |
| Capital expenditure | $140.69MM | $168.06MM | $174.21MM |
| Investing Cash Flow | $-226.65MM | $-266.79MM | $-187.53MM |
| Financing Cash Flow | $-844.04MM | $-837.18MM | $-771.26MM |
| Earnings Per Share** | $7.46 | $9.60 | $2.92 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.